Revvity, Inc.RVTY

$100.00+2.18 (+2.23%)
NYSEHealthcare24:00 UTC

An acquisition-style valuation multiple: Enterprise Value (market cap + net debt) divided by operating earnings before accounting adjustments. Compares companies fairly regardless of their capital structure.

Formula(Market Cap + Net Debt) / EBITDA
Full guide

EV/EBITDA History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
No data available
How to read this chart

Unlike P/E, this metric accounts for debt — two companies with identical operations but different leverage will show similar EV/EBITDA. Low vs history suggests the total business is modestly priced.

Key caveats
  • EBITDA ignores capital expenditure. For asset-heavy businesses (airlines, mining, utilities), this understates the real cost — use EV/EBIT or EV/FCF instead.
  • Large acquisitions temporarily spike net debt and can distort the ratio for 1–2 years during integration.

Is RVTY EV/EBITDA High or Low Right Now?

Revvity, Inc.'s EV/EBITDA is currently 17.7, which is below average relative to its 10-year historical range. The 10-year median EV/EBITDA for RVTY is approximately 19.5. See all RVTY valuation metrics →

Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.